Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Salmon Calcitonin in Postmenopausal Osteoporosis
NCT00525798Phase 3Completed
- Sponsor
- Nordic Bioscience
- Start
- Mar 2007
- Primary completion
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing SMC021 with Placebo (2 arms). Primary endpoint: Number of Patients With New Vertebral Fractures at 36 months. Started Mar 2007; status: completed.
02
Drugs
calcitonin salmon
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00525798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525798.